1. Background {#sec135247}
=============

Breast cancer is the most common type of diagnosed and fatal cancers in females of the most areas of the world, especially in Iran ([@A23131R1], [@A23131R2]). Iran is located in the western part of Asia where breast cancer in women is the first leading cause of death ([@A23131R3]). In comparison with developed countries, breast cancer is diagnosed nearly one decade sooner in Iran and ages of incidence are often in the range of 40 to 49 years ([@A23131R2], [@A23131R4], [@A23131R5]).

Identification of important predictors that prognosis (chance of recovery) of breast cancer depends on them, is a challenging task. There are many prognosis variables in paper and computerized medical records of breast cancer patients. Extraction of the most important predictors among them, regarding outcome variable(s), without using a proper statistical technique may be difficult ([@A23131R5], [@A23131R6]).

A common statistical technique used to find relationships between predictors and outcome is multiple regression analysis (MRA). This technique is suitable when the outcome side has one variable, but applying of it in the scenarios of more than one variable leads to wrong results ([@A23131R7]). Another important issue that must be concerned in multiple regression models is multicollinearity. Existence of the strong correlations between predictors is a major cause of it. As multicollinearity increases, it will be difficult to assess the importance of individual predictors ([@A23131R8]).

In MRA, identification of important predictors is based on their beta weights. Since beta weights are affected by multicollinearity, using an alternative approach ignoring multicollinearity is necessary. Canonical correlation analysis (CCA) developed by Hotelling (1936) is an approach applying structure coefficients as indices for selecting important predictors. Contrary to beta weights, structure coefficients reflect the direct contribution of one predictor to the outcome variable, regardless of the multicollinearity ([@A23131R9]).

Because breast cancer recurs at any time -mainly during the first five years- after the primary treatment, time is considered as an essential factor in the analysis of breast cancer recurrence ([@A23131R6]). The Cox regression method is a traditional statistical one that is suitable for handling events such as cancer recurrence happening during different times ([@A23131R10]). However, since cancer recurrences have different outcomes, the CCA method is preferable.

2. Objectives {#sec135248}
=============

The purpose of this study was to identify the most important risk factors leading to breast cancer recurrence during different time intervals by using the CCA method as a new technique in the clinical domain. The CCA method was applied to data set of breast cancer patients in the capital of Iran (Tehran).

3. Patients and Methods {#sec135252}
=======================

3.1. Data Source {#sec135249}
----------------

In this cross-sectional study, data of 584 female patients (mean age, 45.9 years) were analyzed anonymously. Data were obtained from Breast Cancer Research Center (BCRC) in Tehran, Iran. This center, located in capital of Iran, has multiple clinics related to breast cancer therapy and research. After consulting with oncologists of the research center and studying the literature in the domain ([@A23131R7], [@A23131R11], [@A23131R12]), two sets of predictors and outcomes (see [Box 1.](#tbl34823){ref-type="table"}) were selected.

###### List of Variables in Both Sets

  Variables
  ----------------------------------------------------------
  **Predictor Set**
  Age
  Family history
  Tumor size
  Number of involved LN
  LN positive
  Number of removed LN
  Pathology of tumor
  Type of surgery
  Tumor grade
  Estrogen receptor
  Progesterone receptor
  Radiotherapy
  Hormone therapy
  **Outcome Set** ^**[a](#fn37003){ref-type="table-fn"}**^
  DM, first three years
  DM, 3 - 5 years
  DM, more than 5 years
  LRR, first three years
  LRR, 3 - 5 years
  LRR, more than 5 years

Abbreviations: DM, distant metastasis; LN, lymph node; LRR, loco-regional recurrence.

^a^All periods are time after diagnosis.

3.2. Data Preprocessing {#sec135250}
-----------------------

We obtained the data of this study in the format of Excel file from the BCRC in June 2012 anonymously; so, any special ethical certification was not needed. The original file contained demographic and clinical information of 843 breast cancer patients diagnosed in the BCRC. In the current study, only female patients that had been followed-up 5 years after diagnosis were selected as study samples. As mentioned criteria, 4 male patients and 255 ones that had a follow-up period less than 5 years (60 months) were excluded from the study. As a rule of thumb for minimum sample size calculation in the multivariate techniques that CCA is a subcategory of them, at least 30 observations for each variable are often used ([@A23131R13]) that our study has met this criterion (584 \> 570).

The raw data were transformed and converted as illustrated in [Table 1](#tbl34824){ref-type="table"}. Two variables such as LN positive and LN removed were dichotomized based on their presence or absence in the patients. Other variables, except age, were already categorized. The variable of age, continuous before, was transformed to the dichotomous one.

###### Transformation Rules and the Study Population Characteristics

  Variables                   Coding    Values ^[a](#fn37005){ref-type="table-fn"}^
  --------------------------- --------- ---------------------------------------------
  **Age, y**                            
  \> 50                       0         219 (37.5)
  ≤ 50                        1         365 (62.5)
  **Family history**                    
  No                          0         485 (83)
  First degree                1         99 (17)
  **Tumor size, cm**                    
  (not) \< 2                  \(0\) 1   84 (14.4)
  (not) 2 - 5                 \(0\) 1   268 (45.9)
  (not) \> 5                  \(0\) 1   232 (39.7)
  **Number of involved LN**             
  (not) Nothing               \(0\) 1   231 (39.6)
  (not) 1 - 3                 \(0\) 1   187 (32)
  (not) 3 - 9                 \(0\) 1   112 (19.2)
  (not) \> 9                  \(0\) 1   54 (9.2)
  **LN positive**                       
  No                          0         174 (29.8)
  Yes                         1         410 (70.2)
  **Number of removed LN**              
  Zero                        0         29 (5)
  One or more                 1         381 (95)
  **Pathology of tumor**                
  LCIS                        \(0\) 1   47 (8)
  DCIS                        \(0\) 1   72 (12.3)
  IDC                         \(0\) 1   272 (46.6)
  ILC                         \(0\) 1   95 (16.3)
  Medullary                   \(0\) 1   53 (9.1)
  Micro invasive              \(0\) 1   24 (4.1)
  Paget disease               \(0\) 1   4 (0.7)
  Inflammatory                \(0\) 1   1 (0.2)
  Other                       \(0\) 1   16 (2.7)
  **Type of surgery**                   
  MRM                         \(0\) 1   399 (68.3)
  BCS                         \(0\) 1   135 (23.1)
  Bilateral MRM               \(0\) 1   25 (4.3)
  Bilateral BCS               \(0\) 1   23 (3.9)
  MRM + BCS                   \(0\) 1   1 (0.2)
  Combined                    \(0\) 1   1 (0.2)
  **Tumor grade**                       
  First grade                 1         114 (19.5)
  Second grade                2         319 (54.6)
  Third grade                 3         151 (25.9)
  **Estrogen receptor**                 
  Negative                    0         241 (41.3)
  Positive                    1         343 (58.7)
  **Progesterone receptor**             
  Negative                    0         242 (41.4)
  Positive                    1         342 (58.6)
  **Radiotherapy**                      
  No                          0         220 (37.7)
  Yes                         1         364 (62.3)
  **Hormone therapy**                   
  No                          \(0\) 1   41 (7)
  Tamoxifen                   \(0\) 1   173 (29.6)
  Raloxifene                  \(0\) 1   21 (3.6)
  Letrozole                   \(0\) 1   46 (7.9)
  Aromasin                    \(0\) 1   18 (3.1)
  Megace                      \(0\) 1   16
  Combined                    \(0\) 1   269

Abbreviations: BCS, breast conserving surgery; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LCIS, lobular carcinoma in situ; MRM, modified radical mastectomy; P, preservation.

^a^Values are presented as No. (%).

Although, canonical correlation analysis can accommodate any variable without the strict assumption of normality ([@A23131R14]), the normality tests were done and nonnormal variables (surgery and pathology of tumor) fixed by the log transformation.

Variables with more than 50% of missing values were removed from dataset. Based on this criterion, three variables, age of menopause, tumor margin and Her2 were deleted. Missing values of other variables with less than 50% were substituted using the expectation maximization (EM) algorithm ([@A23131R15]). The EM algorithm is an efficient repetitive procedure to compute the maximum likelihood (ML) estimate in the presence of missing or hidden data. In ML, estimation of the model parameter(s) for which the observed data are the most likely is performed. The E-step and the M-step are two processes that combine iterations of the EM algorithm. The E-step estimates the missing data through the observed data and current estimate of the model parameters and the M-step maximizes the likelihood function under the assumption that the missing data are known ([@A23131R16]).

3.3. Canonical Correlation Analysis {#sec135251}
-----------------------------------

Since two sets of variables existed and outcome set included more than one variable, the CCA method was performed. [Figure 1](#fig25655){ref-type="fig"} illustrates the fundamental principle behind CCA. Simply, the variable relationships in a hypothetical CCA with three predictor and two outcome variables have been shown. The combination of the observed variables in both sets into one unobserved variable is essential for evaluating the simultaneous relationship between several predictor and several outcome variables. In CCA, a linear equation is applied separately to the observed predictor and dependent variables to create one unobserved variable for each set. The reason these two equations are generated is that they yield the largest possible correlation between the two unobserved variables. The canonical correlation between the two unobserved variables is the most basic statistic in a CCA and it almost is a Pearson r (see [Figure 1](#fig25655){ref-type="fig"}). Maximization of this simple correlation is the main purpose of the CCA ([@A23131R17]).

![Illustration of the First Function in a Canonical Correlation Analysis With Three Predictors and Two Criterion Variables](ircmj-18-03-23131-i001){#fig25655}

Furthermore, in a CCA, the number of canonical functions is equal to the number of variables in the smaller set (e.g., two functions for the example in [Figure 1](#fig25655){ref-type="fig"}). The first canonical correlation is the highest possible correlation between any synthetic predictor variable and synthetic outcome variable and is the most proper candidate for interpretation. The criterion for choosing the important variables in each canonical function is the structure coefficients, the bivariate correlation between an observed variable and a synthetic variable. As a rule of thumb for meaningful structure coefficients, an absolute value equal to or greater than 0.45 is often used ([@A23131R17]).

SPSS version 16 for Windows (Chicago, SPSS Inc.; USA) and NORM software (2.03) ([@A23131R18]) were used for data transformation, running and interpretation of CCA and replacing missing values, respectively.

4. Results {#sec135253}
==========

A canonical correlation analysis was conducted using the thirteen attachment variables as predictors of the 6 outcome variables to evaluate the multivariate shared relationship between the two variable sets. The analysis yielded six functions with squared canonical correlations (R^2^~c~) of 0.48, 0.18, 0.1, 0.09, 0.04, 0.02 for each successive function. Collectively, the full model across all functions was statistically significant using the Wilks's λ = 0.32 criterion, F (192, 3235.78) = 3.57, P \< 0.001. Because Wilks's λ represents the variance unexplained by the model, 1 - λ yields the full model effect size in a r^2^ metric. Thus, for the set of six canonical functions, the r^2^ type effect size was 0.68 indicating that the full model explained a substantial portion, about 68%, of the variance shared between the variable sets.

The dimension reduction analysis allows the researcher to test the hierarchal arrangement of functions for statistical significance. As noted, the full model (Functions 1 to 6) was statistically significant. Functions 2 to 6 and 3 to 6 were also statistically significant, F (155, 2711.9) = 1.75, P \< 0.001. F (120, 2181.04) = 1.26, P \< 0.05. Functions 4, 5 and 6, with F (87, 1643.55) = 1.06, P = 0.329, F (56, 1100) = 0.67, P = 0.968 and F (27, 551) = 0.44, P = 0.994 respectively, did not explain a statistically significant amount of shared variance between the variable sets.

Given the R^2^~c~ effects for each function, the first function was considered noteworthy in the context of this study (48% of shared variance). The last five functions only explained 18%, 9.9%, 9.1%, 4.5% and 2.1%, respectively from the remaining variance in the variable sets after the extraction of the prior functions.

[Table 2](#tbl34825){ref-type="table"} presents the standardized canonical function coefficients and structure coefficients for Function 1. The squared structure coefficients are also given for each variable. Looking at the coefficients of the outcome set, one sees that important variables were LRR, more than 5 years and LRR, 3 - 5 years, respectively. This conclusion was supported by the squared structure coefficients. These variables also tended to have the larger canonical function coefficients. All of these variables' structure coefficients had the negative sign, indicating that they were all negatively related.

###### Canonical Solution for Function 1

  Variables                                 Coef     R~3~                                         R^2^~s~, %
  ----------------------------------------- -------- -------------------------------------------- ------------
  **Age**                                   -0.015   -0.163                                       2.65
  **Family history**                        -0.436   -0.795^[a](#fn37007){ref-type="table-fn"}^   63.2
  **Tumor size (\< 2)**                     0.007    0.126                                        1.58
  **Tumor size (2 - 5)**                    0.085    0.414                                        17.13
  **Tumor size (\> 2)**                     0        -0.512^[a](#fn37007){ref-type="table-fn"}^   26.21
  **Number of involved LN (Nothing)**       0.139    0.293                                        8.58
  **Number of involved LN (1 - 3)**         -0.021   -0.081                                       0.65
  **Number of involved LN (3 - 9)**         0.066    0.04                                         0.16
  **Number of involved LN (\> 9)**          0        -0.419                                       17.55
  **LN positive**                           0.061    -0.307                                       9.42
  **Number of removed LN**                  -.021    -0.155                                       2.4
  **Pathology of tumor (LCIS)**             -.408    -0.562^[a](#fn37007){ref-type="table-fn"}^   31.58
  **Pathology of tumor (DCIS)**             -0.259   0.122                                        1.48
  **Pathology of tumor (IDC)**              -0.373   0.492^[a](#fn37007){ref-type="table-fn"}^    24.2
  **Pathology of tumor (ILC)**              -0.545   -0.302                                       9.12
  **Pathology of tumor (Medullary)**        -0.332   -0.041                                       0.16
  **Pathology of tumor (Micro invasive)**   -0.191   -0.045                                       0.2
  **Pathology of tumor (Paget disease)**    -0.153   -0.091                                       0.82
  **Pathology of tumor (Inflammatory)**     -0.164   0.04                                         0.16
  **Pathology of tumor (Other)**            0        0.019                                        0.03
  **Type of surgery (MRM)**                 1.569    0.285                                        8.12
  **Type of surgery (BCS)**                 1.317    0.054                                        0.29
  **Type of surgery (Bilateral MRM)**       0.881    -0.212                                       4.49
  **Type of surgery (Bilateral BCS)**       0.491    -0.558^[a](#fn37007){ref-type="table-fn"}^   31.13
  **Type of surgery (MRM + BCS)**           0.144    0.019                                        0.03
  **Type of surgery (Combined)**            0        -0.119                                       1.41
  **Tumor grade**                           -0.01    0.033                                        0.1
  **Estrogen receptor**                     0.414    0.599^[a](#fn37007){ref-type="table-fn"}^    35.88
  **Progesterone receptor**                 -0.111   0.198                                        3.92
  **Radiotherapy**                          -0.019   -0.069                                       0.47
  **Hormone therapy (Nothing)**             0.161    0.112                                        1.25
  **Hormone therapy (Tamoxifen)**           0.147    0.278                                        7.72
  **Hormone therapy (Raloxifene)**          0.041    -0.025                                       0.06
  **Hormone therapy (Letrozole)**           0.113    0.218                                        4.75
  **Hormone therapy (Aromasin)**            0.056    0.06                                         .36
  **Hormone therapy (Megace)**              -0.012   0.025                                        0.06
  **Hormone therapy (Combined)**            0        -0.451^[a](#fn37007){ref-type="table-fn"}^   20.34
  **R** ^**2**^ ~**c**~                                                                           9.12
  **DM, first three years**                 0.173    0.209                                        4.36
  **DM, 3 - 5 years**                       0.175    0.2                                          4
  **DM, more than 5 years**                 0.074    -0.058                                       0.33
  **LRR, first three years**                -0.437   -0.356                                       12.67
  **LRR, 3 - 5 years**                      -0.564   -0.479^[a](#fn37007){ref-type="table-fn"}^   22.94
  **LRR, more than 5 years**                -0.739   -0.686^[a](#fn37007){ref-type="table-fn"}^   47.05

Abbreviations: Coef, standardized canonical function coefficient; r~s~, structure coefficient; r~s~^2^, squared structure coefficient, R^2^~c~, squared canonical correlations.

^a^Structure coefficients (r~s~) greater than 0.45 are underlined.

Regarding the predictor variable set in Function 1, family history, estrogen receptor, pathology of tumor (LCIS), type of surgery (bilateral BCS), tumor size (\> 2), pathology of tumor (IDC), and hormone therapy (combined) had the highest coefficients, respectively. Structure coefficients of all of them were negative, except for variables of estrogen receptor and pathology of tumor (IDC) that had positive sign.

5. Discussion {#sec135254}
=============

In this study, applying of the CCA method leads to identification of variables: family history, estrogen receptor, pathology of tumor, type of surgery, tumor size and hormone therapy, as important factors in predicting LRR, more than 5 years and LRR, 3 - 5 years.

Within the general linear models (i.e. CCA), r^2^ type effect sizes are the first point for considering ([@A23131R19]). Reporting results only with P values (without effect sizes) has little or no information about the importance of results ([@A23131R20]). Our study's statistical significance and effect sizes demonstrate that there is a remarkable relationship between our variable sets.

As Sherry ([@A23131R17]), structure coefficients are answer to the question "what variables are contributing to the relationship between the variables set across the functions?" So, they are critical for deciding what variables are useful for the model ([@A23131R9]).

The variable of family history, which got the highest structure coefficient, is a common and important predictor for the prognosis of breast cancer ([@A23131R21], [@A23131R22]). The second variable among predictors set (based on its structure coefficient) is estrogen receptor. This variable is a significant one that has an inverse relation with outcome variables. In patients who have ER positive breast cancers local recurrence occurs less common. The estrogen receptor positive cancers, need to estrogen in order to grow and multiply, are less aggressive than negative ones and have better prognosis ([@A23131R23]-[@A23131R25]). Pathology plays an important part in determining the treatment strategy for women with breast cancer, with the evaluation of breast specimens determining the surgical and the oncological therapeutic options used ([@A23131R26], [@A23131R27]). In this study, variable of pathology of tumor values got third and sixth places among predictors. Type of surgery is a pertinent risk factor of breast cancer affecting mortality rate of this disease and has different mental and physical consequences on various age categories of patients ([@A23131R28], [@A23131R29]). Tumor size ([@A23131R24], [@A23131R30], [@A23131R31]) and hormone therapy ([@A23131R32]), were also found to be important predictors in the present study.

Some researchers have detected progesterone receptor as a prognostic factor in predicting breast cancer recurrence, especially in accompanying with estrogen receptor ([@A23131R7], [@A23131R33]), whereas this variable did not get enough structure coefficients for reporting as important predictor in our study. Lyman ([@A23131R34]), Paik ([@A23131R35]) and Arvold ([@A23131R36]) have showed that variable of age is an important factor in detecting the breast cancer recurrence, although age has not been determined as an important one in the present study.

Lymph node removed, number of involved LN, LN positive, radiotherapy and tumor grade were not detected as predictors of breast cancer recurrence in this research. Razavi ([@A23131R7]) in a nearly similar study to the current study determined DM during the first four years and LRR during the first two years after diagnosis as outcome variables related to the predictor variables. In our study, LRR between three and five years and LRR more than five years were detected as outcome variables.

Dissimilarities between detected variables in our study and any other similar studies could be due to: geographical difference, nature of population studied and finally the way of data preprocessing.

There are two important limitations in the current study. First, some important variables that probably had great potential to exist among other significant risk factors were removed in our study because they had not enough values for analyzing; so, some valuable information were missed. Second, this study was performed in a single institution and consequently the generalization of its results is weaker than population-based studies.

In this study, the CCA was applied on the variables selected after consulting with experienced clinicians to achieve the medical meaningfulness and identification of most important risk factors leading to breast cancer recurrence during different time intervals.

In the medical complicated cases, for example the breast cancer disease that contains considerable numbers of variables (risk factors) in the predictor set and usually more than one variable in the outcome set, applying CCA as a new solution for detecting important ones in both sets is an appropriate selection. Detected breast cancer risk factors in this study were consistent with clinical guidelines.
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